Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02717013 · ClinicalTrials.gov registry record · NA
The Effect of HMB Supplementation on Adipose Tissue Inflammation and Metabolism
A NA study, sponsored by Metabolic Technologies.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02717013: Clinical Trial NA study, sponsored by Metabolic Technologies.
NCT02717013 is a NA study that was terminated before completion, run by Metabolic Technologies. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02717013, a NA study, was terminated before completion, sponsored by Metabolic Technologies.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will determine the effects of supplementing beta-hydroxy-beta-methylbutyrate (HMB) on body composition and strength changes during weight loss. When overweight and obese persons lose weight, and in particular in conjunction with dietary restrictions, muscle, bone mass, and muscle strength are also lost. HMB has been shown to preserve muscle mass and strength, and it is thought that HMB may also preserve muscle, bone, and strength during weight-loss.
Primary Outcome
Bone mineral density measured by DXA (T-score)
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT HMB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-02 |
| Phase | NA |
Why NCT02717013 stopped before completion
NCT02717013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02717013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02717013 about?
NCT02717013 is a clinical study titled "The Effect of HMB Supplementation on Adipose Tissue Inflammation and Metabolism". This study will determine the effects of supplementing beta-hydroxy-beta-methylbutyrate (HMB) on body composition and strength changes during weight loss. When overweight and obese persons lose weight, and in particular in conjunction with dietary restrictions, muscle, bone mass, and muscle strength...
What is the current status of trial NCT02717013?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2016-03. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02717013?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), HMB (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02717013?
This trial is sponsored by Metabolic Technologies, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02717013's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia